RAS Pathway Mutation is an Added-Value Biomarker in Pediatric Philadelphia-negative B-cell Acute Lymphoblastic Leukemia with IKZF1 Deletions
Pediatric Blood & Cancer（2021）
Key words
IKZF1 deletion,pediatric,Philadelphia-negative B-ALL,RAS pathway gene mutation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined